We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+9.26%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+548.24%
AUM
$726B
AUM Growth
+$72B
Cap. Flow
+$18.3B
Cap. Flow %
2.52%
Top 10 Hldgs %
22.02%
Holding
4,790
New
331
Increased
3,384
Reduced
720
Closed
74

Sector Composition

Rank Sector Weight
1 Technology 23.98%
2 Financials 13.87%
3 Healthcare 13.39%
4 Consumer Discretionary 11.81%
5 Communication Services 10.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRCN
4651
DELISTED
Burcon NutraScience Corporation
BRCN
$52K ﹤0.01%
+18,667
New +$59.7K
RCON icon
4652
Recon Technology
RCON
$32.6M
$51K ﹤0.01%
667
-227
-25% -$33.1K
TOPS icon
4653
TOP Ships
TOPS
$3.69M
$51K ﹤0.01%
134
PLUR icon
4654
Pluri
PLUR
$16.8M
$50K ﹤0.01%
1,586
LFWD icon
4655
ReWalk Robotics
LFWD
$19.7M
$50K ﹤0.01%
353
GRNQ icon
4656
Greenpro Capital
GRNQ
$21.1M
$49K ﹤0.01%
3,755
-69
-2% -$1.15K
SIFY
4657
Sify Technologies
SIFY
$1.06B
$49K ﹤0.01%
2,284
+472
+26% +$9.28K
NVOS
4658
DELISTED
Novo Integrated Sciences, Inc. Common Stock
NVOS
$49K ﹤0.01%
+1,986
New +$49.5K
AWX icon
4659
Avalon Holdings
AWX
$9.87M
$48K ﹤0.01%
10,366
YJ
4660
Yunji
YJ
$5.81M
$48K ﹤0.01%
700
-549
-44% -$42.1K
BTOG icon
4661
Bit Origin
BTOG
$2.19M
$47K ﹤0.01%
17
PRHI
4662
Presurance Holdings
PRHI
$18.7M
$47K ﹤0.01%
2,387
BRN icon
4663
Barnwell Industries
BRN
$13.9M
$46K ﹤0.01%
14,145
FAMI icon
4664
Farmmi Inc
FAMI
$5.87M
$46K ﹤0.01%
+43
New +$64.3K
IMMP
4665
Immutep
IMMP
$56M
$46K ﹤0.01%
+12,131
New +$48K
CSCI
4666
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
$46K ﹤0.01%
531
ELYS
4667
DELISTED
Elys Game Technology, Corp. Common Stock
ELYS
$46K ﹤0.01%
+11,486
New +$52.4K
PHCF
4668
DELISTED
Puhui Wealth Investment Management Co., Ltd.
PHCF
$46K ﹤0.01%
+1,991
New +$48.6K
BTCT icon
4669
BTC Digital
BTCT
$8.75M
$45K ﹤0.01%
78
+37
+90% +$31.8K
OCC icon
4670
Optical Cable Corp
OCC
$125M
$45K ﹤0.01%
12,030
BAOS icon
4671
Baosheng Media Group
BAOS
$967K
$44K ﹤0.01%
+681
New +$50.7K
RDGT
4672
Ridgetech Inc
RDGT
$2.87M
$44K ﹤0.01%
1
INBS icon
4673
Intelligent Bio Solutions
INBS
$3.76M
$43K ﹤0.01%
+5
New +$47.8K
MDIA icon
4674
Mediaco Holding
MDIA
$81.5M
$43K ﹤0.01%
+12,132
New +$41.4K
ARMP icon
4675
Armata Pharmaceuticals
ARMP
$175M
$40K ﹤0.01%
10,188

Similar funds

Geode Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Geode Capital Management held 4,790 positions worth $726B, up 11% from $654B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Geode Capital Management's Q2 2021 filing shows 331 new, 3,384 increased, 720 reduced and 74 closed positions. Its largest new stake was Organon & Co: 5,070,121 shares worth $153M. The largest sale was Sherwin-Williams, an estimated $1.88B.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

  • Geode Capital Management's largest Q2 2021 buy was Organon & Co: 5,070,121 shares worth $153M.
  • Geode Capital Management added most to Microsoft in Q2 2021, an estimated $786M increase.
  • Geode Capital Management's biggest Q2 2021 reduction was Sherwin-Williams, cutting an estimated $1.88B.
  • Geode Capital Management fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $274M.
  • Geode Capital Management's ten largest holdings make up 22% of its $726B portfolio in Q2 2021.
  • Geode Capital Management opened 331 new positions and closed 74 in Q2 2021.
  • Geode Capital Management's portfolio value rose 11% quarter-over-quarter to $726B.

Based on Geode Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.